FdaApplication

NDA 217593

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNANJING DELOVA BIOTECH CO LTD
application_typeNDA
approval_date2025-04-22

Products (1)

ProductActive ingredientStrengthDosage form
QAMZOVAMELOXICAM30MG/ML (30MG/ML)SOLUTION;INTRAVENOUS

1 product